LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹22 Cr | ₹19 Cr | ₹15 Cr | ₹38 Cr | ₹11 Cr |
What is the latest Total Non-Current Liabilities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹22 Cr |
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹11 Cr |
How is Total Non-Current Liabilities of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹22 Cr | 13.63 | |
| Mar2025 | ₹19 Cr | 25.99 | |
| Mar2024 | ₹15 Cr | -60.08 | |
| Mar2023 | ₹38 Cr | 245.81 | |
| Mar2022 | ₹11 Cr | - | |
Compare Total Non-Current Liabilities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,027.3 Cr | -0.9% | -3.6% | 2.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -0.9% |
-3.6% |
2.9% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses